Embryonic stem cells have the potential to treat a range of diseases and conditions for which current treatment options are lacking. Capable of differentiating practically into all of the types of tissues in the human body, the cells could be used in therapies to treat conditions such as paralysis, brain damage, and Parkinson’s disease. Among the many challenges to be overcome before human embryonic stem cells live up to their promise is difficulty in proving whether transplanted stem cells can integrate successfully in vivo.
Researchers from University of Wisconsin-Madison have announced progress on that front. Having created Read more »
*This blog post was originally published at Medgadget*